Peptide Atlas · Peptide

AOD-9604

AOD9604 is a synthetic analogue of the lipolytic domain of human growth hormone, taken from the hormone's C-terminus.

preclinical

provisional
PubChem 71300630
2 citations
0 discussions
0 followers
Anti-Obesity Drug 9604
Tyr-hGH frag 176-191
hGH Fragment 177-191 modified

Follow this molecule Ask the Hunter-Gatherer

What the evidence says

six tiers, never blended

preclinical — animal, cell or mechanistic work — not yet about people

every claim resolves to its source

All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.

- preclinical
  Claim: Oral AOD9604 reduced weight gain in obese Zucker rats without impairing insulin sensitivity standing
- resolved
Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone.
Ng FM, Sun J, Sharma L, Libinaka R, Jiang WJ, Gianello R
pmid 11146367
- preclinical
  Claim: Lipolytic action of hGH and AOD9604 in obese and beta-3 receptor knock-out mice standing
- resolved
The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice.
Heffernan M, Summers RJ, Thorburn A, Ogru E, Gianello R, Jiang WJ, Ng FM
pmid 11713213

A claim's standing is its latest row in an append-only history; a tombstone names the later evidence and the reason. The Graveyard and the Resurrection Yard.

Negative findings

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.